- United States
- /
- Chemicals
- /
- NYSE:ECL
Ecolab (ECL) Valuation Check As Executive Reshuffle And Strong Earnings Draw Fresh Attention
Ecolab (ECL) is back in focus after a strong Q4 earnings release and a significant leadership reshuffle, including splitting the chief operating officer role into two positions effective April 1, 2026.
See our latest analysis for Ecolab.
At a share price of $298.46, Ecolab has seen a 12.91% 90 day share price return and a 12.61% 1 year total shareholder return. The recent dip after earnings follows a 5.84% 30 day share price gain and a much stronger 95.30% 3 year total shareholder return, suggesting longer term momentum remains stronger than the latest pullback.
If these leadership changes have you reassessing your watchlist, it could be a good moment to broaden your search with our screener of 18 top founder-led companies.
With Ecolab trading at $298.46, sitting below an average analyst price target of $321.86 and alongside solid recent earnings, the key question is whether the current valuation still leaves upside on the table or whether the market is already pricing in future growth.
Most Popular Narrative: 7.3% Undervalued
With Ecolab closing at $298.46 against a widely followed fair value narrative of about $321.86, the story hinges on how margins and growth evolve from here.
Investments in digital technologies have led to improved productivity, resulting in a 190-basis-point increase in operating income margin. Continued investment in these technologies is anticipated to enhance earnings and operating margins further.
Curious what sits behind that margin story and the higher fair value tag. The narrative leans on steady revenue gains and firmer profitability assumptions. It also ties everything back to a richer earnings profile a few years out. Want to see how those moving parts add up.
Result: Fair Value of $321.86 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, softer industrial demand and higher local supplier costs could squeeze margins and make it harder for Ecolab to reach the earnings profile implied by the fair value.
Find out about the key risks to this Ecolab narrative.
Another Angle On Valuation
Those fair value narratives lean on earnings power and margin improvement, but the current P/E of 40.5x tells a different story. It sits well above the US Chemicals industry at 24x and the peer average at 30.2x, and even above a fair ratio of 25.4x, which points to meaningful valuation risk if sentiment cools.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
If this mix of potential upside and risks feels finely balanced, now is a good time to look through the numbers yourself and decide where you stand. You can start with our breakdown of 1 key reward and 1 important warning sign.
Looking for more investment ideas?
If you are weighing what to do next after Ecolab, this is the moment to widen your net with a few high quality, data backed stock ideas.
- Target resilient income by checking companies we flag as potential 15 dividend fortresses that could suit investors who want yield front and center.
- Zero in on value by scanning our list of 49 high quality undervalued stocks that pair quality fundamentals with prices that may not fully reflect their strengths.
- Spot tomorrow's potential leaders early through our screener containing 24 high quality undiscovered gems that highlight lesser known names with solid underlying metrics.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Ecolab might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:ECL
Ecolab
Provides water, hygiene, and infection prevention solutions and services in the United States and internationally.
Adequate balance sheet average dividend payer.
Similar Companies
Market Insights
Weekly Picks

The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake
NVIDIA will see a profit margin surge of 55% in the next 5 years
Bambuser is today the only listed company in Europe that simultaneously possesses an 85% gross margin, proprietary AI infrastructure for the

Constellium jet another cyclical aluminum processor, or a mispriced aluminum platform?
Recently Updated Narratives
TROPHY GAMES Development Will See Revenue Rise by 22% in the Next 3 Years
NVIDIA will see a profit margin surge of 55% in the next 5 years
Springer REE deposit valuation
Popular Narratives

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

The academically fascinating Tesla
